Sensor-augmented pump therapy: review of new NICE diagnostic guidance-Reference-Cited by-同舟云学术

Sensor-augmented pump therapy: review of new NICE diagnostic guidance

Published:2016-03 Issue:2 Volume:33 Page:47-48a
ISSN:2047-2897
Container-title:Practical Diabetes
language:en
Short-container-title:Pract Diab

Author:

Raj Suchitra¹,Chakera Ali²

Affiliation:

1. King's College Hospital NHS Foundation Trust; London UK

2. Royal Sussex County Hospital, Brighton and Sussex University Hospitals NHS Trust; Brighton UK

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pdi.1999/fullpdf

Reference8 articles.

1. Home use of an artificial beta cell in type 1 diabetes;Thabit;N Engl J Med,2015

2. NICE diagnostic guidance (DG21) February 2016 Integrated sensor-augmented pump therapy systems for managing blood glucose levels in type 1 diabetes (the MiniMed Paradigm Veo system and the Vibe and G4 Platinum CGM system) www.nice.org.uk/guidance/dg21

3. STAR 3 study group. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes;Bergenstal;N Engl J Med,2010

4. Sensor-augmented pump therapy lowers HbA1c in suboptimally controlled type 1 diabetes; a randomized controlled trial;Hermanides;Diabet Med,2011

5. Combined insulin pump therapy with real-time continuous glucose monitoring significantly improves glycemic control compared to multiple daily injection therapy in pump naïve patients with type 1 diabetes; single center pilot study experience;Lee;J Diabetes Sci Technol,2007

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Network Meta-Analyses Investigating Efficacy of Diabetes Monitoring Systems with Insulin Delivery in Patients with Type-1 Diabetes, Using Non-Randomized Studies, Randomized-Controlled Trials, or Both as Evidence;2024

2. Health professionals' views about who would benefit from using a closed‐loop system: a qualitative study;Diabetic Medicine;2020-02-14